Advertisement

The possible function and regulation of macrophage migration inhibitory factor (MIF) in multiple sclerosis (MS)

  • Simone Hjæresen
    Correspondence
    Corresponding author at: University of Southern Denmark, Department of Molecular Medicine, J.B. Winsløws vej 21, 5000 Odense, Denmark.
    Affiliations
    University of Southern Denmark, Department of Molecular Medicine, J.B. Winsløws vej 21, 5000 Odense, Denmark

    BRIDGE – Brain Research InterDisciplinary Guided Excellence, University of Southern Denmark, Odense, Denmark
    Search for articles by this author
  • Åsa Fex Svenningsen
    Affiliations
    University of Southern Denmark, Department of Molecular Medicine, J.B. Winsløws vej 21, 5000 Odense, Denmark

    BRIDGE – Brain Research InterDisciplinary Guided Excellence, University of Southern Denmark, Odense, Denmark
    Search for articles by this author
      We thank Harirchian et al. for their interest in our newly published paper: “MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis” [
      • Hjæresen S.
      • Sejbaek T.
      • Axelsson M.
      • Kl S.
      • Vinsl H.
      • Pihl-jensen G.
      • et al.
      MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis.
      ] and would very much like to comment and answer the questions raised in “The enigmatic role of Macrophage Inhibitory Factor (MIF) in the pathogenesis of Multiple Sclerosis (MS)”.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hjæresen S.
        • Sejbaek T.
        • Axelsson M.
        • Kl S.
        • Vinsl H.
        • Pihl-jensen G.
        • et al.
        MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis.
        J. Neurol. Sci. 2022; 439
        • Axelsson M.
        • Malmeström C.
        • Gunnarsson M.
        • Zetterberg H.
        • Sundström P.
        • Lycke J.
        • et al.
        Immunosuppressive Therapy Reduces Axonal Damage in Progressive Multiple Sclerosis.
        2014
        • Sejbaek T.
        • Nielsen H.H.
        • Penner N.
        • Plavina T.
        • Mendoza J.P.
        • Martin N.A.
        • et al.
        Dimethyl Fumarate Decreases Neurofilament Light Chain in CSF and Blood of Treatment Naïve Relapsing.
        (MS patients)2019: 1324-1330
        • Blanca M.J.
        • Alarcón R.
        • Arnau J.
        • Bono R.
        • Bendayan R.
        Non-normal data: Is ANOVA still a valid option?.
        Psicothema. 2017; 29: 552-557
        • GJP Breukelen
        • Candel M.J.J.M.
        • Berger M.P.F.
        Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
        Stat. Med. 2007; 26: 2589-2603
        • Bentzen J.
        • Flachs E.M.
        • Stenager E.
        • Brønnum-Hansen H.
        • Koch-Henriksen N.
        Prevalence of multiple sclerosis in Denmark 1950-2005.
        Mult. Scler. Int. 2010; 16 (Available from:): 520-525
        • Kremenchutzky M.
        • Rice G.P.A.
        • Baskerville J.
        • Wingerchuk D.M.
        • Ebers G.C.
        The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
        Brain. 2006; 129: 584-594
        • Confavreux C.
        • Vukusic S.
        Natural history of multiple sclerosis: a unifying concept.
        Brain. 2006; 129: 606-616
        • Rijvers L.
        • Melief M.J.
        • van der Vuurst de Vries R.M.
        • Stéphant M.
        • van Langelaar J.
        • Wierenga-Wolf A.F.
        • et al.
        The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.
        Eur. J. Immunol. 2018; 48: 1861-1871
        • Bacher M.
        • Meinhardt A.
        • Lan H.Y.
        • Dhabhar F.S.
        • Mu W.
        • Metz C.N.
        • et al.
        MIF expression in the rat brain: implications for neuronal function.
        Mol. Med. 1998; 4: 217-230
        • Ogata A.
        • Nishihira J.
        • Suzuki T.
        • Nagashima K.
        • Tashiro K.
        Identification of Macrophage Migration Inhibitory Factor mRNA Expression in Neural Cells of the Rat Brain by In Situ Hybridization.
        246. 1998: 173-177
        • Bernhagen J.
        • Krohn R.
        • Lue H.
        • Gregory J.L.
        • Zernecke A.
        • Koenen R.R.
        • et al.
        MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
        Nat. Med. 2007; 13: 587-596
        • Mitchell R.A.
        • Liao H.
        • Chesney J.
        • Fingerle-Rowsor G.
        • Baugh J.
        • David J.
        • et al.
        Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.
        Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 345-350
        • Onodera S.
        • Suzuki K.
        • Matsuno T.
        • Kaneda K.
        • Takagi M.
        • Nishihira J.
        Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion.
        Immunology. 1997; 92: 131-137
        • Alampour-Rajabi S.
        • El Bounkari O.
        • Rot A.
        • Müller-Newen G.
        • Bachelerie F.
        • Gawaz M.
        • et al.
        MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis.
        FASEB J. 2015; 29: 4497-4511
        • Gore Y.
        • Starlets D.
        • Maharshak N.
        • Becker-Herman S.
        • Kaneyuki U.
        • Leng L.
        • et al.
        Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex.
        J. Biol. Chem. [Internet]. 2008; 283 (Available from:): 2784-2792
        • Su Y.
        • Wang Y.
        • Zhou Y.
        • Zhu Z.
        • Zhang Q.
        • Zhang X.
        Macrophage Migration Inhibitory Factor Activates Inflammatory Responses of Astrocytes through Interaction with CD74 Receptor.
        8(2). 2017: 2719-2730
        • Zhang Y.
        • Gu R.
        • Jia J.
        • Hou T.
        • Zheng L.T.
        • Zhen X.
        Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
        Clin. Exp. Pharmacol. Physiol. 2016; 43: 1134-1144
        • Zheng L.T.
        • Chen J.
        • Zhang L.
        • Zhang Y.
        • Xu L.
        • Hou T.
        • et al.
        Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312).
        Int. Immunopharmacol. 2021; 98
        • Wang F.Z.
        • Wu H.B.
        • Xu S.Q.
        • Guo X.R.
        • Yang J.
        • Shen X.F.
        Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia.
        Neurosci. Res. [Internet]. 2011; 71 (Available from:): 210-218
        • Kassaar O.
        • Morais M.P.
        • Xu S.
        • Adam E.L.
        • Chamberlain R.C.
        • Jenkins B.
        • et al.
        Macrophage migration inhibitory factor is subjected to glucose modification and oxidation in Alzheimer’s disease.
        Sci. Rep. [Internet]. 2017; 7 (Available from:): 1-11
        • Lassmann H.
        Multiple sclerosis pathology.
        Cold Spring Harb. Perspect. Med. 2018; 8: 1-16
        • Li S.
        • Nie K.
        • Zhang Q.
        • Guo M.
        • Qiu Y.
        • Li Y.
        • et al.
        Macrophage migration inhibitory factor mediates neuroprotective effects by regulating inflammation, apoptosis and autophagy in Parkinson’s disease.
        Neuroscience [Internet]. 2019; 416 (Available from:): 50-62
        • Zhang S.
        • Zhao J.
        • Zhang Y.
        • Zhang Y.
        • Cai F.
        • Wang L.
        • et al.
        Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease.
        Alzheimers Res. Ther. 2019; 11: 1-12
        • Jin C.
        • Shao Y.
        • Zhang X.
        • Xiang J.
        • Zhang R.
        • Sun Z.
        • et al.
        A unique type of highly-activated microglia evoking brain inflammation via Mif/Cd74 signaling Axis in aged mice.
        Aging Dis. 2021; 12: 2125-2139